Showing results 1 to 50 from more than 300,000 results:

Indolent Lymphoma: Top KOLs in the world



World Rank Name Topic PersonRank Score help
#1
T Andrew Lister
St Bartholomew's Hospital London, London, United Kingdom. |
Also Ranks for:
Bone Marrow
Acute Leukaemia
Myeloablative Therapy
Complete Remission
follicular lymphoma
Indolent Lymphoma1000
#2
Bertrand B Coiffier
Department of Hematology, Hospices Civils de Lyon, 3 Quai de
Also Ranks for:
Cell Lymphoma
Monoclonal Antibodies
Elderly Patients
Diffuse Large
board directors
Indolent Lymphoma500
#3
Richard I Fisher
Centre for Biostatistics and Clinical Trials, Peter MacCallu
Also Ranks for:
Cell Lymphoma
Consultancy Funding
Monoclonal Antibodies
Diffuse Large
southwest oncology
Indolent Lymphoma333
#4
Julie ***** **** (Reveal full name)
University of Nebraska Medical Center | Division of Hematolo
Also Ranks for:
Cell Lymphoma
Board Directors
Advisory Committees
Speakers Bureau
consultancy funding
Indolent LymphomaReveal score
#5
Sandra * ******* (Reveal full name)
Department of Medicine, Stanford University, Stanford, CA, U
Also Ranks for:
Follicular Lymphoma
Maintenance Rituximab
Monoclonal Antibodies
Hodgkin Disease
large cell
Indolent LymphomaReveal score
#6
Anton ********* (Reveal full name)
Cancer Center Amsterdam, Amsterdam University Medical Center
Also Ranks for:
Bone Marrow
Follicular Lymphoma
Leukemic Cells
Rat Model
rituximab maintenance
Indolent LymphomaReveal score
#7
James **** ******** (Reveal full name)
From the Department of Emergency Medicine and the New Mexico
Also Ranks for:
Bone Marrow
Complete Remission
Autologous Transplantation
United States
cell lymphoma
Indolent LymphomaReveal score
#8
Bruce * ****** (Reveal full name)
Lymphoma Research Foundation, United States. | Lymphoma, Lym
Also Ranks for:
Speakers Bureau
Board Directors
Follicular Lymphoma
Advisory Committees
consultancy funding
Indolent LymphomaReveal score
#9
Fernando * ********** (Reveal full name)
University of Puerto Rico School of Medicine and Auxilio Mut
Also Ranks for:
Cell Lymphoma
Puerto Rico
Hodgkin Disease
Bone Marrow
combination chemotherapy
Indolent LymphomaReveal score
#10
Peter * ********** (Reveal full name)
Department of Lymphoma and Myeloma, The University of Texas
Also Ranks for:
Monoclonal Antibodies
Bone Marrow
Molecular Response
Ibritumomab Tiuxetan
follicular lymphoma
Indolent LymphomaReveal score
#11
Randy * ******** (Reveal full name)
Lymphoid Cancer Research, BC Cancer Research, Vancouver, Can
Also Ranks for:
Diffuse Large
Gene Expression
British Columbia
Consultancy Honoraria
cell lymphoma
Indolent LymphomaReveal score
#12
Hervé ***** (Reveal full name)
Centre Henri-Becquerel, Rouen, France | INSERM U1245, Centre
Also Ranks for:
Board Directors
Advisory Committees
Follicular Lymphoma
Consultancy Honoraria
Indolent LymphomaReveal score
#13
Joseph ******* ******* (Reveal full name)
Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC V5Z 1L3
Also Ranks for:
Hodgkin Lymphoma
Consultancy Honoraria
Seattle Genetics
British Columbia
brentuximab vedotin
Indolent LymphomaReveal score
#14
Wolfgang * ********* (Reveal full name)
Department of Medicine III, Ludwig-Maximilians-University Ho
Also Ranks for:
Honoraria Funding
Bone Marrow
Board Directors
Acute Myeloid Leukemia
follicular lymphoma
Indolent LymphomaReveal score
#15
Pier ***** ***** ******* (Reveal full name)
IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto
Also Ranks for:
Advisory Committees
Consultancy Honoraria
Speakers Bureau
Board Directors
Indolent LymphomaReveal score
#16
Emanuele ***** (Reveal full name)
Department of Oncology, IOSI—Oncology Institute of Southern
Also Ranks for:
Marginal Zone
Honoraria Funding
Board Directors
Advisory Committees
cell lymphoma
Indolent LymphomaReveal score
#17
Corinne ****** (Reveal full name)
Groupe Hospitalier Albert Mondor, Val De Marne, France; | AP
Also Ranks for:
Cell Lymphoma
Board Directors
Advisory Committees
Consultancy Membership
honoraria funding
Indolent LymphomaReveal score
#18
Martin * ******** (Reveal full name)
Department of Medicine III, LMU Hospital, Munich, Germany |
Also Ranks for:
Mantle Cell Lymphoma
Board Directors
Advisory Committees
Honoraria Funding
speakers bureau
Indolent LymphomaReveal score
#19
Richard * ***** (Reveal full name)
Department of Radiation Oncology, Stanford University, Stanf
Also Ranks for:
Hodgkin Lymphoma
Sézary Syndrome
Stanford University
Mycosis Fungoides
radiation therapy
Indolent LymphomaReveal score
#20
Gilles ***** ****** (Reveal full name)
Memorial Sloan Kettering Cancer Center, New York | Memorial
Also Ranks for:
Follicular Lymphoma
Speakers Bureau
Board Directors
Advisory Committees
consultancy honoraria
Indolent LymphomaReveal score
#21
Armando *************** (Reveal full name)
Department of Hematology, Hospital Clinic, Barcelona, Spain;
Also Ranks for:
Consultancy Honoraria
Chronic Lymphocytic Leukemia
Board Directors
Advisory Committees
follicular lymphoma
Indolent LymphomaReveal score
#22
Philippe ************* (Reveal full name)
Institut de Cancérologie de l'Ouest René Gauducheau, Saint-H
Also Ranks for:
Monoclonal Antibodies
Rituximab Treatment
Elderly Patients
Interferon Alfa
follicular lymphoma
Indolent LymphomaReveal score
#23
Catherine * ****** (Reveal full name)
Centre Léon Bérard, LYON, France. | Hematologie, Centre Leon
Also Ranks for:
Follicular Lymphoma
Elderly Patients
Complete Remission
Febrile Neutropenia
12 months
Indolent LymphomaReveal score
#24
Fredrick * *********** (Reveal full name)
Department of Lymphoma and Myeloma, The University of Texas
Also Ranks for:
Consultancy Funding
Cell Lymphoma
Hodgkin Disease
Board Directors
advisory committees
Indolent LymphomaReveal score
#25
Elaine * ***** (Reveal full name)
National Cancer Institute. | Laboratory of Pathology, Center
Also Ranks for:
Lymphoid Neoplasms
Situ Hybridization
Cyclin D1
Gene Expression
cell lymphoma
Indolent LymphomaReveal score
#26
GrilloLopez ************ (Reveal full name)
agrillo1@aol.com | PO Box 3797, Rancho Santa Fé, CA 92067, U
Also Ranks for:
Follicular Lymphoma
Ibritumomab Tiuxetan
Murinederived Antigens
Chop Chemotherapy
monoclonal antibodies
Indolent LymphomaReveal score
#27
Norbert ******* (Reveal full name)
Department of Population-Based Medicine, Institute of Health
Also Ranks for:
Cell Transplantation
Type 2 Diabetes
Mental Disorders
Bone Marrow
depressive symptoms
Indolent LymphomaReveal score
#28
Nancy *** ****** (Reveal full name)
Department of Pathology, Massachusetts General Hospital/Harv
Also Ranks for:
Abdominal Pain
Cyclin D1
Lymphoid Neoplasms
Diagnosis Differential
cell lymphoma
Indolent LymphomaReveal score
#29
Leo * ****** (Reveal full name)
Northwestern University Feinberg School of Medicine and the
Also Ranks for:
Consultancy Funding
Speakers Bureau
Cell Lymphoma
Sarah Cannon Institute
ibritumomab tiuxetan
Indolent LymphomaReveal score
#30
Jonathan * ********* (Reveal full name)
James P. Wilmot Cancer Institute, University of Rochester Me
Also Ranks for:
Follicular Lymphoma
Board Directors
Advisory Committees
Brentuximab Vedotin
consultancy funding
Indolent LymphomaReveal score
#31
Massimo * ********** (Reveal full name)
Stefano Luminari, MD, Hematology Unit, AUSL-IRCCS of Reggio
Also Ranks for:
Breast Cancer
Fondazione Italiana Linfomi
Elderly Patients
Consultancy Funding
follicular lymphoma
Indolent LymphomaReveal score
#32
Pauline ***** (Reveal full name)
Department of Hematology, Saint‐Louis Hospital, AP‐HP, Paris
Also Ranks for:
Brentuximab Vedotin
Board Directors
Hodgkin Lymphoma
Advisory Committees
honoraria funding
Indolent LymphomaReveal score
#33
Umberto ****** (Reveal full name)
Department of Medical Oncology, Candiolo Cancer Institute, F
Also Ranks for:
Follicular Lymphoma
Consultancy Honoraria
Board Directors
Speakers Bureau
advisory committees
Indolent LymphomaReveal score
#34
Michael ********* (Reveal full name)
University Hospital of the Ludwig-Maximilians-University Mun
Also Ranks for:
Speakers Bureau
Honoraria Funding
Mantle Cell
European Mcl Network
follicular lymphoma
Indolent LymphomaReveal score
#35
Myron ****** ******** (Reveal full name)
NoveCite Inc, Cranford, NJ, United States | NoveCite, Inc |
Also Ranks for:
Monoclonal Antibodies
Follicular Lymphoma
Consultancy Funding
Speakers Bureau
board directors
Indolent LymphomaReveal score
#36
Noel **** ******* (Reveal full name)
CHU Bordeaux, Pessac. | Hematology and Cell Therapy Departme
Also Ranks for:
Stem Cell
Acute Leukemia
Marrow Transplantation
Host Disease
complete remission
Indolent LymphomaReveal score
#37
Andrew ***** ******** (Reveal full name)
Memorial Sloan Kettering Cancer Center, New York, NY; | Memo
Also Ranks for:
Board Directors
Advisory Committees
Seattle Genetics
Follicular Lymphoma
consultancy funding
Indolent LymphomaReveal score
#38
David * ******* (Reveal full name)
Clinical Research Division, Fred Hutchinson Cancer Research
Also Ranks for:
Consultancy Funding
Cell Transplantation
Nonmyeloablative Conditioning
Speakers Bureau
multiple myeloma
Indolent LymphomaReveal score
#39
Catherine *********** (Reveal full name)
APHP, Haemato‐Oncology Department, Saint Louis Hospital, Par
Also Ranks for:
Board Directors
Speakers Bureau
Advisory Committees
Cell Lymphoma
consultancy honoraria
Indolent LymphomaReveal score
#40
John ******* ******* (Reveal full name)
Peter MacCallum Cancer Centre and the Royal Melbourne Hospit
Also Ranks for:
Board Directors
Advisory Committees
Speakers Bureau
Follicular Lymphoma
honoraria funding
Indolent LymphomaReveal score
#41
PierreLouis ********* (Reveal full name)
Université de Bordeaux, institut Bergonié, Inserm UMR11312,
Also Ranks for:
Erythropoietic Proteins
Geriatric Assessment
Functional Decline
Elderly Patients
follicular lymphoma
Indolent LymphomaReveal score
#42
Lorenz * ******** (Reveal full name)
Universitätsmedizin Göttingen, Goettingen, Germany; | Depart
Also Ranks for:
Gene Expression
Diffuse Large
Elderly Patients
Situ Hybridization
cell lymphoma
Indolent LymphomaReveal score
#43
Brian * **** (Reveal full name)
University of Iowa Hospitals and Clinics, Holden Comprehensi
Also Ranks for:
United States
Board Directors
Speakers Bureau
Follicular Lymphoma
consultancy funding
Indolent LymphomaReveal score
#44
Jorge ******* * ********* (Reveal full name)
Department of Lymphoma & Myeloma, MD Anderson Cancer Center,
Also Ranks for:
Honoraria Funding
Board Directors
Advisory Committees
Monoclonal Antibodies
cell lymphoma
Indolent LymphomaReveal score
#45
John * ******* (Reveal full name)
Centre for Haemato-Oncology, Barts Cancer Institute, Queen M
Also Ranks for:
Honoraria Funding
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Bone Marrow
speakers bureau
Indolent LymphomaReveal score
#46
Fritz * ****** (Reveal full name)
Universitair Ziekenhuis Gent, Gent, Belgium; | Universitair
Also Ranks for:
Speakers Bureau
Board Directors
Advisory Committees
Consultancy Membership
honoraria funding
Indolent LymphomaReveal score
#47
David * ********** (Reveal full name)
Department of Academic Surgery, The Royal Marsden Hospital,
Also Ranks for:
Consultancy Funding
Board Directors
Neoadjuvant Chemotherapy
Monoclonal Antibodies
colorectal cancer
Indolent LymphomaReveal score
#48
Jan ******* ******** (Reveal full name)
Maria Sklodowska-Curie National Research Institute of Oncolo
Also Ranks for:
Brentuximab Vedotin
Board Directors
Advisory Committees
Consultancy Honoraria
speakers bureau
Indolent LymphomaReveal score
#49
Thomas * ****** (Reveal full name)
Division of Hematology, Mayo Clinic, Rochester, MN; | Mayo C
Also Ranks for:
Multiple Myeloma
Cell Lymphoma
Consultancy Funding
Board Directors
ibritumomab tiuxetan
Indolent LymphomaReveal score
#50
Ronald * **** (Reveal full name)
Stanford University School of Medicine | Division of Oncolog
Also Ranks for:
Tumor Cells
Monoclonal Antibodies
Board Directors
Free Energy
follicular lymphoma
Indolent LymphomaReveal score
1
2
3
4
5
6
»

Recently Asked Questions

Primary Cns Lymphoma Primary central nervous system lymphoma (PCNSL) is a type of non-Hodgkin lymphoma that starts in the brain or the spinal cord. It is a rare cancer,...

Indolent Lymphoma Indolent lymphoma is a type of cancer that develops slowly and usually does not cause symptoms. It is the most common type of non-Hodgkin lymphoma,...